Macrophage‐Hepatocyte Circuits Mediated by Grancalcin Aggravate the Progression of Metabolic Dysfunction Associated Steatohepatitis

Macrophage‐Hepatocyte Circuits Mediated by Grancalcin Aggravate the Progression of Metabolic Dysfunction Associated Steatohepatitis

Abstract The dynamic interplay between parenchymal hepatocytes and non‐parenchymal cells (NPCs), such as macrophages, is an important mechanism for liver metabolic homeostasis. Although numerous endeavors have been made to identify the mediators of metabolic dysfunction associated steatohepatitis (M...

Full description

Saved in:

Bibliographic Details
Main Authors:	Tian Su, Yue He, Min Wang, Haiyan Zhou, Yan Huang, Mingsheng Ye, Qi Guo, Ye Xiao, Guangping Cai, Mingyang Zhao, Jianping Wang, Xianghang Luo
Format:	Article
Language:	English
Published:	Wiley 2024-11-01
Series:	Advanced Science
Subjects:	GCA macrophage‐hepatocyte metabolic dysfunction associated steatohepatitis
Online Access:	https://doi.org/10.1002/advs.202406500
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Deposition features of heterovalent iron (Fe2 + and Fe3 +) in the liver in alcoholic and nonalcoholic steatohepatitis
by: V. A. Tumanskiy, et al.
Published: (2015-12-01)

Ethanol Disrupts the Protective Crosstalk Between Macrophages and HBV-Infected Hepatocytes
by: Murali Ganesan, et al.
Published: (2025-01-01)

TRIB3 Is a Hub Gene in Steatohepatitis and Aggravates Lipid Deposition and Inflammation in Hepatocytes
by: Xia W, et al.
Published: (2025-04-01)

Changes in direct markers of liver fibrosis in patients with steatohepatitis non-alcoholic and alcoholic origin on the background of obesity and pathology of the biliary tract
by: A. Yu. Filippova
Published: (2017-04-01)

Cholesterol overload in macrophages drives metabolic dysfunction-associated steatohepatitis via inhibiting 7-dehydrocholesterol reductase in mice
by: Xiaoxiao Li, et al.
Published: (2024-11-01)

Imeglimin Halts Liver Damage by Improving Mitochondrial Dysfunction in a Nondiabetic Male Mouse Model of Metabolic Dysfunction-Associated Steatohepatitis
by: Kosuke Kaji, et al.
Published: (2024-11-01)

E2F2 Reprograms Macrophage Function By Modulating Material and Energy Metabolism in the Progression of Metabolic Dysfunction‐Associated Steatohepatitis
by: Zheng Liu, et al.
Published: (2024-12-01)

Therapeutic Actions of Hepatocyte Extracellular Vesicles in a Murine Model of Diet-Induced Steatohepatitis with Fibrosis
by: Xinlei Li, et al.
Published: (2025-01-01)

Huc-MSCs-derived exosomes alleviate non-alcoholic steatohepatitis by regulating macrophages polarization through miR-24-3p/STING axis
by: Wei Jiang, et al.
Published: (2025-02-01)

15-17 May 2024, 16th Global Communication Association Conference “The Future(s) of Communication: Promises and Predicaments”
by: Büşra Tosun Durmuş
Published: (2024-12-01)

1,25-dihydroxyvitamin D3 improves non-alcoholic steatohepatitis phenotype in a diet-induced rat model
by: Mei Liu, et al.
Published: (2025-03-01)

Characterizing morphological heterogeneity in porcine hepatocytes
by: KIRPAL SINGH, et al.
Published: (2025-02-01)

Influencing factors and mechanism of hepatocyte regeneration
by: Xiaoyi Zhang, et al.
Published: (2025-04-01)

Application of ursodeoxycholic acid at non-alcoholic and alcohol-induced steatohepatitis
by: Ye. A. Fedos’ina, et al.
Published: (2010-06-01)

Exosomal novel-miRNA-126 mediates vascular endothelial dysfunction by targeting AhR-NLRP3 pathway in nonalcoholic steatohepatitis
by: Qiuhe Chen, et al.
Published: (2025-03-01)

Mechanisms of transcriptional control of glucose metabolism in hepatocytes
by: Konstantin Y. Kulebyakin, et al.
Published: (2016-07-01)

TRANSPLANTATION OF HEPATOCYTES AS THE METHOD OF TREATMENT OF LIVER FAILURE: EXPERIMENTAL AND CLINICAL EXPERIENCE
by: M. Y. Shagidulin, et al.
Published: (2010-06-01)

Sulforaphane ameliorates non-alcoholic steatohepatitis by KLF4-mediated macrophage M2 polarization
by: Xianghui Huang, et al.
Published: (2024-09-01)

Clinical and pathogenetic differences of the course of flow nonalcoholic steatohepatitis in obese patients with and without hypertension
by: O.S. Khukhlina, et al.
Published: (2013-08-01)

The effectiveness of the integrated use of gepadif, ezetrol and fosinopril in the nonalcoholic steatohepatitis in patients with hypertension stage II
by: O. S. Khukhlina, et al.
Published: (2017-03-01)

Steatohepatitis in Children with Obesity
by: Alexander A. Zvyagin, et al.
Published: (2021-08-01)

Mitochondrial area in the cytoplasm of mice hepatocytes on high-fat diet treated with metformin
by: Milošević Sara, et al.
Published: (2024-01-01)

Corrigendum: Pyroptosis and gasdermins—Emerging insights and therapeutic opportunities in metabolic dysfunction-associated steatohepatitis
by: Christian Stoess, et al.
Published: (2024-10-01)

The unforeseen intracellular lifestyle of Enterococcus faecalis in hepatocytes
by: Natalia Nunez, et al.
Published: (2022-12-01)

Rutin Ameliorates BHBA-Induced Inflammation and Lipid Accumulation in Calf Hepatocytes Through NF-κB Signaling Pathway
by: Kun Yang, et al.
Published: (2025-04-01)

Ductular reaction in alcoholic steatohepatitis, nonalcoholic steatohepatitis and hepatitis C virus infection (immunohistochemical study)
by: O. M. Gavrilyuk
Published: (2014-04-01)

How the ultrasound protocol may improve the timely diagnosis of cerebrovascular complications in giant cell arteritis
by: Beatrice Maranini, et al.
Published: (2025-07-01)

l-carnitine protects against bile acid-induced mitochondrial dysfunction and IGF-1 impairment in hepatocyte cultures
by: Wafa'a Alqabandi, et al.
Published: (2025-06-01)

Drug Therapy for Non-Alcoholic Steatohepatitis-Induced Liver Fibrosis
by: D. V. Garbuzenko
Published: (2022-01-01)

Comparative analysis of small molecule and growth factor-derived human induced pluripotent stem cell-derived hepatocyte-like cells
by: Faizal Z. Asumda, et al.
Published: (2025-06-01)

DNA replication in primary hepatocytes without the six-subunit ORC
by: Róża K Przanowska, et al.
Published: (2025-04-01)

Central Retinal Artery Occlusion as the Initial Manifestation of Occult Giant Cell Arteritis - A Diagnostic Enigma
by: Muthukrishnan Vallinayagam, et al.
Published: (2019-07-01)

Liver Regeneration as a Model for Studying Cellular Plasticity in Mammals: The Roles of Hepatocytes and Cholangiocytes
by: Andrey Elchaninov, et al.
Published: (2025-07-01)

PREVALENCE AND RISK FACTORS ASSOCIATED WITH NON-ALCOHOLIC STEATOHEPATITIS IN PATIENTS WITH RHEUMATOID ARTHRITIS ON HYDROXYCHLOROQUINE: A POPULATION-BASED STUDY
by: Antoine BOUSTANY, et al.
Published: (2025-04-01)

Impact of Post-Thaw Enrichment of Primary Human Hepatocytes on Steatosis, Inflammation, and Fibrosis in the TruVivo<sup>®</sup> System
by: Justin J. Odanga, et al.
Published: (2024-12-01)

Diagnostics of progression of liver fibrosis in patients with non-alcoholic steatohepatitis combined with obesity and chronic calculous cholecystitis.
by: A. Yu. Filippova
Published: (2020-04-01)

Decreased expression of insulin-degrading enzyme increases gluconeogenesis and glucose production in cultured hepatocytes administered with glucagon
by: Carlos M. González-Casimiro, et al.
Published: (2025-05-01)

Kidney Biopsy Findings in People With Metabolic Dysfunction–Associated Steatohepatitis
by: Evgeniya Pasternak, et al.
Published: (2025-05-01)

Comprehensive profiling of candidate biomarkers and immune infiltration landscape in metabolic dysfunction-associated steatohepatitis
by: Zhangliu Jin, et al.
Published: (2025-06-01)

The spectrum of giant cell arteritis and polymyalgia rheumatica: a longitudinal prospective study to assess for subclinical giant cell arteritis in new onset polymyalgia rheumatica
by: Yasser El Miedany, et al.
Published: (2025-02-01)